Capstone Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$529K Buy
1,503
+3
+0.2% +$1.07K 0.03% 98
2025
Q4
$491K Buy
1,500
+4
+0.3% +$1.27K 0.03% 97
2025
Q3
$422K Buy
1,496
+10
+0.7% +$2.9K 0.02% 110
2025
Q2
$415K Sell
1,486
-182
-11% -$51.6K 0.02% 107
2025
Q1
$520K Buy
1,668
+3
+0.2% +$886 0.03% 90
2024
Q4
$434K Sell
1,665
-656
-28% -$195K 0.03% 95
2024
Q3
$748K Buy
2,321
+393
+20% +$129K 0.05% 74
2024
Q2
$602K Buy
1,928
+3
+0.2% +$881 0.04% 77
2024
Q1
$547K Buy
1,925
+47
+3% +$13.8K 0.04% 80
2023
Q4
$541K Buy
1,878
+3
+0.2% +$817 0.04% 78
2023
Q3
$504K Sell
1,875
-161
-8% -$40.2K 0.04% 75
2023
Q2
$452K Sell
2,036
-71
-3% -$16.5K 0.03% 82
2023
Q1
$509K Sell
2,107
-147
-7% -$36.1K 0.04% 71
2022
Q4
$592K Sell
2,254
-306
-12% -$82K 0.05% 63
2022
Q3
$577K Sell
2,560
-39
-2% -$9.45K 0.05% 63
2022
Q2
$632K Buy
2,599
+5
+0.2% +$1.23K 0.05% 65
2022
Q1
$627K Buy
2,594
+10
+0.4% +$2.3K 0.05% 66
2021
Q4
$581K Buy
2,584
+295
+13% +$62.3K 0.04% 69
2021
Q3
$487K Buy
2,289
+321
+16% +$73.9K 0.04% 70
2021
Q2
$480K Buy
1,968
+46
+2% +$11.3K 0.04% 72
2021
Q1
$478K Buy
1,922
+18
+0.9% +$4.29K 0.04% 64
2020
Q4
$438K Buy
1,904
+253
+15% +$58.3K 0.04% 65
2020
Q3
$420K Buy
1,651
+1
+0.1% +$248 0.04% 54
2020
Q2
$389K Buy
1,650
+2
+0.1% +$456 0.04% 50
2020
Q1
$334K Buy
1,648
+170
+12% +$37.1K 0.04% 48
2019
Q4
$356K Buy
1,478
+2
+0.1% +$441 0.05% 57
2019
Q3
$286K Sell
1,476
-84
-5% -$16.1K 0.04% 67
2019
Q2
$287K Sell
1,560
-84
-5% -$15K 0.05% 65
2019
Q1
$312K Buy
1,644
+173
+12% +$33K 0.05% 61
2018
Q4
$286K Buy
1,471
+152
+12% +$29.7K 0.06% 59
2018
Q3
$273K Buy
1,319
+1
+0.1% +$197 0.07% 62
2018
Q2
$243K Sell
1,318
-352
-21% -$62.3K 0.07% 64
2018
Q1
$285K Sell
1,670
-85
-5% -$15.6K 0.09% 54
2017
Q4
$305K Sell
1,755
-111
-6% -$19.6K 0.11% 52
2017
Q3
$348K Buy
1,866
+349
+23% +$61.8K 0.15% 46
2017
Q2
$261K Sell
1,517
-93
-6% -$15.1K 0.13% 54
2017
Q1
$264K Sell
1,610
-101
-6% -$16.8K 0.13% 47
2016
Q4
$250K Sell
1,711
-98
-5% -$14.7K 0.11% 53
2016
Q3
$302K Sell
1,809
-22
-1% -$3.72K 0.16% 45
2016
Q2
$279K Sell
1,831
-94
-5% -$14.6K 0.15% 46
2016
Q1
$289K Buy
1,925
+204
+12% +$30.3K 0.11% 50
2015
Q4
$279K Buy
1,721
+45
+3% +$7.07K 0.1% 49
2015
Q3
$232K Sell
1,676
-31
-2% -$4.89K 0.1% 53
2015
Q2
$262K Sell
1,707
-501
-23% -$80.3K 0.1% 64
2015
Q1
$353K Buy
2,208
+4
+0.2% +$630 0.14% 51
2014
Q4
$351K Buy
2,204
+712
+48% +$111K 0.11% 50
2014
Q3
$210K Buy
+1,492
New +$195K 0.13% 52

Other funds holding AMGN

Capstone Financial Advisors's AMGN Position: Q1 2026 in Review

Capstone Financial Advisors increased its Amgen (AMGN) stake by 0.2% in Q1 2026, buying an estimated $1.07K and bringing the position to 1,503 shares worth $529K. The position accounts for 0.03% of the portfolio, ranked #98.

Capstone Financial Advisors first reported a position in AMGN in Q3 2014 and has held it in 47 quarters since. The position peaked at $748K in Q3 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Capstone Financial Advisors held 1,503 shares of Amgen worth $529K as of Q1 2026.
  • Capstone Financial Advisors bought 3 Amgen shares in Q1 2026, an estimated $1.07K.
  • Amgen made up 0.03% of Capstone Financial Advisors's portfolio in Q1 2026, its #98 holding.
  • Capstone Financial Advisors first reported a position in Amgen in Q3 2014 and has held it in 47 quarters since.
  • Capstone Financial Advisors's Amgen position peaked at $748K in Q3 2024.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Capstone Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.